1847 related articles for article (PubMed ID: 11059782)
21. MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule).
Degen WG; van Kempen LC; Gijzen EG; van Groningen JJ; van Kooyk Y; Bloemers HP; Swart GW
Am J Pathol; 1998 Mar; 152(3):805-13. PubMed ID: 9502422
[TBL] [Abstract][Full Text] [Related]
22. Endothelial expression of vascular cell adhesion molecule-1 correlates with metastatic pattern in spontaneous melanoma.
Langley RR; Carlisle R; Ma L; Specian RD; Gerritsen ME; Granger DN
Microcirculation; 2001 Oct; 8(5):335-45. PubMed ID: 11687945
[TBL] [Abstract][Full Text] [Related]
23. Two human melanoma cell-line variants with enhanced in vivo tumor growth and metastatic capacity do not express the beta 3 integrin subunit.
Boukerche H; Benchaibi M; Berthier-Vergnes O; Lizard G; Bailly M; Bailly M; McGregor JL
Eur J Biochem; 1994 Mar; 220(2):485-91. PubMed ID: 8125107
[TBL] [Abstract][Full Text] [Related]
24. Role of beta-1 integrins in organ specific adhesion of melanoma cells in vitro.
Vink J; Thomas L; Etoh T; Bruijn JA; Mihm MC; Gattoni-Celli S; Byers HR
Lab Invest; 1993 Feb; 68(2):192-203. PubMed ID: 7680081
[TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms of melanoma metastasis.
Bar-Eli M
J Cell Physiol; 1997 Nov; 173(2):275-8. PubMed ID: 9365536
[TBL] [Abstract][Full Text] [Related]
26. Metastatic phenotype: growth factor dependence and integrin expression.
Perrotti D; Cimino L; Falcioni R; Tibursi G; Gentileschi MP; Sacchi A
Anticancer Res; 1990; 10(6):1587-97. PubMed ID: 2285230
[TBL] [Abstract][Full Text] [Related]
27. The alpha 3 beta 1 integrin is involved in melanoma cell migration and invasion.
Melchiori A; Mortarini R; Carlone S; Marchisio PC; Anichini A; Noonan DM; Albini A
Exp Cell Res; 1995 Jul; 219(1):233-42. PubMed ID: 7628538
[TBL] [Abstract][Full Text] [Related]
28. Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44.
Birch M; Mitchell S; Hart IR
Cancer Res; 1991 Dec; 51(24):6660-7. PubMed ID: 1742741
[TBL] [Abstract][Full Text] [Related]
29. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.
Xie S; Luca M; Huang S; Gutman M; Reich R; Johnson JP; Bar-Eli M
Cancer Res; 1997 Jun; 57(11):2295-303. PubMed ID: 9187135
[TBL] [Abstract][Full Text] [Related]
30. Up-regulation of growth hormone receptor immunoreactivity in human melanoma.
Lincoln DT; Sinowatz F; Kölle S; Takahashi H; Parsons P; Waters M
Anticancer Res; 1999; 19(3A):1919-31. PubMed ID: 10470136
[TBL] [Abstract][Full Text] [Related]
31. The expression of tumor-associated antigens in primary and metastatic human malignant melanoma.
Brüggen J; Bröcker EB; Suter L; Redmann K; Sorg C
Behring Inst Mitt; 1984 May; (74):19-23. PubMed ID: 6477352
[TBL] [Abstract][Full Text] [Related]
32. Detection of malignant melanoma with monoclonal antibodies.
Saxton RE; Burke MW; Torbett B; Fairhurst M; Morton DL; Cochran AJ
Dis Markers; 1988 Jun; 6(2):97-108. PubMed ID: 3042264
[TBL] [Abstract][Full Text] [Related]
33. A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo.
McGary EC; Heimberger A; Mills L; Weber K; Thomas GW; Shtivelband M; Lev DC; Bar-Eli M
Clin Cancer Res; 2003 Dec; 9(17):6560-6. PubMed ID: 14695161
[TBL] [Abstract][Full Text] [Related]
34. Blocking a novel 55 kDa melanoma-associated cell surface antigen inhibits the development of spontaneous metastases and interactions with frozen lung section.
Baril P; Nejjari M; Scoazek JY; Boukerche H
Int J Cancer; 2002 May; 99(3):315-22. PubMed ID: 11992398
[TBL] [Abstract][Full Text] [Related]
35. Identification of a secreted Mr 95,000 glycoprotein in human melanocytes and melanomas by a melanocyte specific monoclonal antibody.
Vogel AM; Esclamado RM
Cancer Res; 1988 Mar; 48(5):1286-94. PubMed ID: 3342407
[TBL] [Abstract][Full Text] [Related]
36. Identification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells.
Shahan TA; Ziaie Z; Pasco S; Fawzi A; Bellon G; Monboisse JC; Kefalides NA
Cancer Res; 1999 Sep; 59(18):4584-90. PubMed ID: 10493512
[TBL] [Abstract][Full Text] [Related]
37. Isolation and functional characterization of the A32 melanoma-associated antigen.
Shih IM; Elder DE; Speicher D; Johnson JP; Herlyn M
Cancer Res; 1994 May; 54(9):2514-20. PubMed ID: 8162602
[TBL] [Abstract][Full Text] [Related]
38. The differential reactivity of cells of the melanocytic lineage with four monoclonal antibodies against IFN-gamma inducible molecules.
Vacca A; Frassanito A; Rimoldi D; Dammacco F; Carrel S
Anticancer Res; 1992; 12(1):1-9. PubMed ID: 1348919
[TBL] [Abstract][Full Text] [Related]
39. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
Wollina U; Kilian U; Henkel U; Schaarschmidt H; Knopf B
Anticancer Res; 1991; 11(4):1405-14. PubMed ID: 1746897
[TBL] [Abstract][Full Text] [Related]
40. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
